British Journal of Cancer · 2004 · 71 citations · 27 references
Life SciencesCell BiologyOncologyApoptosisMetastasisMolecular OncologyApoptosis In CancerApoptosis RegulationApoptotic SignalingColorectal CancerExtrinsic Apoptotic PathwayIntrinsic Apoptotic PathwayCancer Cell Line ModelsCo-culture ModelsConfocal Fluorescence MicroscopyDeath Ligand SignalingFas LigandFas Ligand-mediated ApoptosisFas Receptor SignalingPhase-contrast Microscopy
Gastrointestinal carcinomas frequently disseminate within the abdominal cavity to form secondary peritoneal metastases. Invasion of the peritoneal mesothelium is fundamental to this process, yet the underlying invasive mechanisms remain unclear. Preliminary in vitro work suggested that tumour cells can induce mesothelial apoptosis, representing a novel mechanism of peritoneal invasion. We examined the role of tumour cell-induced mesothelial apoptosis and explored the role of the death ligand/receptor system, Fas Ligand/Fas, as mediators of the apoptotic process. Cultured human mesothelial cells were used to establish in vitro co-culture models with the SW480 colonic cancer cell line. Tumour-induced mesothelial apoptosis was confirmed by phase-contrast microscopy and apoptotic detection assays. Human mesothelial cells and SW480 tumour cells constitutively expressed Fas and Fas Ligand mRNA and protein as determined by RT-PCR and confocal fluorescent microscopy. Stimulation of human mesothelial cells with anti-Fas monoclonal antibody or crosslinked soluble Fas Ligand-induced apoptosis, confirming the functional status of the Fas receptor. Pretreatment of SW480 cells with a blocking recombinant anti-Fas Ligand monoclonal antibody significantly reduced mesothelial apoptosis, indicating that tumour-induced mesothelial apoptosis may, in part, be mediated via a Fas-dependent mechanism. This represents a novel mechanism of mesothelial invasion and offers several new targets for therapeutic intervention.
27
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher et al. · Science · 1995 · 2K citations
Medicine, Immunology, Ophthalmology +17
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations
Life Sciences, Immunology, Oncology +17
A role for CD95 ligand in preventing graft rejection
Donald Bellgrau, Daniel P. Gold, Helena Selawry et al. · Nature · 1995 · 1.2K citations